NASDAQ : ADVB
Advanced Biomed Inc. — Financial statements
Healthcare · Diagnostics & Research · United States
Last price 2.3 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.80M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Advanced Biomed Inc. (ADVB) reported revenue of 127.64K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Revenue | 127.64K | 127.64K | ||||
| Gross Profit | 127.64K | 127.64K | ||||
| Selling, General & Admin | 4.63M | 4.63M | 1.09M | 1.66M | 1.69M | 754.84K |
| Research & Development | 880.19K | 1.38M | 1.62M | |||
| Operating Expenses | 6.36M | 6.36M | 1.09M | 2.54M | 3.07M | 2.37M |
| Operating Income | -6.23M | -6.23M | -1.09M | -2.54M | -3.07M | -2.37M |
| Interest Expense | -7.01K | -7.01K | ||||
| Interest & Investment Income | 53.49K | 21.40K | 243.00 | |||
| Currency Exchange Gain (Loss) | -294.69K | -511.64K | ||||
| Other Non Operating Income (Expenses) | -21.93K | -21.93K | 486.00 | -21.11K | -35.62K | |
| EBT Excluding Unusual Items | -6.26M | -6.26M | -1.09M | -2.78M | -3.58M | -2.41M |
| Impairment of Goodwill | -1.62M | |||||
| Gain (Loss) on Sale of Assets | -150.21K | |||||
| Pretax Income | -6.26M | -6.26M | -1.09M | -2.78M | -3.73M | -4.03M |
| Income Tax Expense | -1.21K | -1.21K | ||||
| Earnings From Continuing Operations | -6.26M | -6.26M | -1.09M | -2.78M | -3.73M | -4.03M |
| Earnings From Discontinued Operations | 12.94M | 12.94M | -2.17M | |||
| Net Income | 6.68M | 6.68M | -3.26M | -2.78M | -3.73M | -4.03M |
| Net Income to Common | 6.68M | 6.68M | -3.26M | -2.78M | -3.73M | -4.03M |
| Shares Outstanding (Basic) | 1.25M | 1.25M | 1.03M | 1.00M | 996.79K | 709.19K |
| Shares Outstanding (Diluted) | 1.25M | 1.25M | 1.03M | 1.00M | 996.79K | 709.19K |
| EPS (Basic) | 5.33 | 5.33 | -3.18 | -2.78 | -3.74 | -5.68 |
| EPS (Diluted) | 5.33 | 5.33 | -3.18 | -2.78 | -3.74 | -5.68 |
| Free Cash Flow | -1.95M | -1.95M | -5.83M | -2.20M | -3.17M | -1.63M |
| Free Cash Flow Per Share | -1.55 | -1.55 | -5.68 | -2.20 | -3.19 | -2.30 |
| Gross Margin | 100.00% | 100.00% | ||||
| Operating Margin | -4,883.81% | -4,883.81% | ||||
| Profit Margin | 5,231.30% | 5,231.30% | ||||
| Free Cash Flow Margin | -1,525.38% | -1,525.38% | ||||
| EBITDA | -6.17M | -6.17M | -742.64K | -2.14M | -2.84M | -2.26M |
| D&A For EBITDA | 59.28K | 59.28K | 343.83K | 399.60K | 228.81K | 114.89K |
| EBIT | -6.23M | -6.23M | -1.09M | -2.54M | -3.07M | -2.37M |
Balance sheet
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 385.54K | 385.54K | 31.14K | 2.61M | 2.62M | 4.78M |
| Cash & Short-Term Investments | 385.54K | 385.54K | 31.14K | 2.61M | 2.62M | 4.78M |
| Other Receivables | 13.36M | 13.36M | 205.18K | 149.95K | 162.52K | |
| Receivables | 13.36M | 13.36M | 205.18K | 149.95K | 162.52K | |
| Prepaid Expenses | 2.00K | 2.00K | 1.84M | 237.96K | 13.76K | 59.33K |
| Other Current Assets | 20.51M | |||||
| Total Current Assets | 13.75M | 13.75M | 22.38M | 3.05M | 2.79M | 5.01M |
| Property, Plant & Equipment | 651.27K | 954.07K | 1.23M | |||
| Other Intangible Assets | 119.00K | 250.32K | 410.80K | |||
| Long-Term Deferred Tax Assets | 1.20K | 1.20K | ||||
| Long-Term Deferred Charges | 638.87K | 553.47K | ||||
| Other Long-Term Assets | 479.77K | 56.13K | 71.02K | |||
| Total Assets | 13.75M | 13.75M | 22.86M | 4.46M | 4.60M | 6.71M |
| Accounts Payable | 620.48K | 632.82K | 762.20K | |||
| Accrued Expenses | 373.82K | 373.82K | 533.84K | 80.66K | 85.56K | 96.20K |
| Short-Term Debt | 1.08M | 1.08M | 784.53K | |||
| Current Portion of Leases | 62.21K | 216.57K | 236.68K | |||
| Other Current Liabilities | 21.95K | 21.95K | 18.71M | 1.18M | 2.34M | 1.89M |
| Total Current Liabilities | 1.47M | 1.47M | 19.24M | 2.73M | 3.28M | 2.99M |
| Long-Term Leases | 64.53K | 18.81K | 232.19K | |||
| Other Long-Term Liabilities | 145.65K | |||||
| Total Liabilities | 1.47M | 1.47M | 19.38M | 2.80M | 3.29M | 3.22M |
| Common Stock | 1.65K | 1.65K | 1.08K | 20.00K | 20.00K | 99.00K |
| Additional Paid-In Capital | 23.86M | 23.86M | 21.37M | 16.49M | 13.67M | 12.58M |
| Retained Earnings | -12.56M | -12.56M | -19.23M | -15.97M | -13.19M | -9.46M |
| Comprehensive Income & Other | 968.88K | 968.88K | 1.34M | 1.12M | 804.02K | 268.86K |
| Shareholders' Equity | 12.28M | 12.28M | 3.48M | 1.66M | 1.31M | 3.49M |
| Total Liabilities & Equity | 13.75M | 13.75M | 22.86M | 4.46M | 4.60M | 6.71M |
| Total Debt | 1.08M | 1.08M | 911.27K | 235.37K | 468.87K | |
| Net Cash (Debt) | -692.68K | -692.68K | 31.14K | 1.70M | 2.39M | 4.31M |
| Net Cash Per Share | -0.55 | -0.55 | 0.03 | 1.70 | 2.39 | 6.08 |
| Filing Date Shares Outstanding | 1.65M | 1.65M | 1.08M | 1.00M | 1.00M | 1.00M |
| Total Common Shares Outstanding | 1.65M | 1.65M | 1.08M | 1.00M | 1.00M | 990.00K |
| Working Capital | 12.28M | 12.28M | 3.14M | 318.65K | -489.60K | 2.02M |
| Book Value Per Share | 7.43 | 7.43 | 3.21 | 1.66 | 1.31 | 3.53 |
| Tangible Book Value | 12.28M | 12.28M | 3.48M | 1.54M | 1.06M | 3.08M |
| Tangible Book Value Per Share | 7.43 | 7.43 | 3.21 | 1.54 | 1.06 | 3.11 |
| Machinery | 1.55M | 1.51M | 1.38M | |||
| Leasehold Improvements | 201.52K | 201.99K | 212.08K |
Cash flow statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | 6.68M | 6.68M | -3.26M | -2.78M | -3.73M | -4.03M |
| Depreciation & Amortization | 399.60K | 228.81K | 114.89K | |||
| Other Amortization | 136.42K | 11.74K | ||||
| Loss (Gain) From Sale of Assets | 150.21K | 37.63K | ||||
| Asset Writedown & Restructuring Costs | 1.62M | |||||
| Stock-Based Compensation | 1.73M | 1.73M | ||||
| Provision & Write-off of Bad Debts | 2.92M | 2.92M | ||||
| Other Operating Activities | -12.44M | -12.44M | 2.17M | |||
| Change in Accounts Payable | -431.64K | -431.64K | 615.81K | 479.63K | 381.25K | 912.42K |
| Change in Other Net Operating Assets | 579.87K | 579.87K | -1.84M | -223.30K | -127.54K | 591.61K |
| Operating Cash Flow | -1.95M | -1.95M | -5.83M | -2.13M | -2.96M | -741.45K |
| Capital Expenditures | -74.11K | -210.88K | -889.59K | |||
| Sale of Property, Plant & Equipment | 28.92K | |||||
| Cash Acquisitions | 199.53K | |||||
| Divestitures | -2.58M | -2.58M | -50.49K | |||
| Sale (Purchase) of Intangibles | -1.64K | -422.54K | ||||
| Other Investing Activities | 75.76K | 75.76K | -31.65K | |||
| Investing Cash Flow | -2.51M | -2.51M | -31.65K | -74.11K | -263.01K | -1.08M |
| Short-Term Debt Issued | 294.90K | |||||
| Long-Term Debt Issued | 1.08M | 1.08M | 274.98K | 1.66M | ||
| Total Debt Issued | 1.08M | 1.08M | 274.98K | 1.95M | ||
| Net Debt Issued (Repaid) | 1.08M | 1.08M | 274.98K | 1.95M | ||
| Issuance of Common Stock | 248.00K | 248.00K | 5.49M | 1.01M | 6.10M | |
| Other Financing Activities | 641.76K | 641.76K | 165.53K | -85.40K | -553.47K | |
| Financing Cash Flow | 1.97M | 1.97M | 5.93M | 1.87M | 458.14K | 6.10M |
| Foreign Exchange Rate Adjustments | -33.32K | -33.32K | 218.35K | 319.32K | 606.91K | 445.94K |
| Net Cash Flow | -2.52M | -2.52M | 295.94K | -14.31K | -2.16M | 4.72M |
| Free Cash Flow | -1.95M | -1.95M | -5.83M | -2.20M | -3.17M | -1.63M |
| Free Cash Flow Margin | -1,525.38% | -1,525.38% | ||||
| Free Cash Flow Per Share | -1.55 | -1.55 | -5.68 | -2.20 | -3.19 | -2.30 |
| Levered Free Cash Flow | -12.02M | -12.02M | -5.23M | -2.72M | -1.40M | 686.17K |
| Unlevered Free Cash Flow | -12.02M | -12.02M | -5.23M | -2.72M | -1.40M | 686.17K |
| Change in Working Capital | 148.22K | 148.22K | -1.22M | 256.34K | 253.71K | 1.50M |
Ratios
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 3.80M | 7.68M | 15.15M | |||
| Enterprise Value | 4.49M | 5.78M | 12.03M | |||
| Last Close Price | 2.30 | 4.65 | 14.00 | |||
| PE Ratio | 0.43 | 1.15 | ||||
| PS Ratio | 29.77 | 60.19 | ||||
| PB Ratio | 0.31 | 0.63 | 4.36 | |||
| P/TBV Ratio | 0.31 | 0.63 | 4.36 | |||
| EV/Sales Ratio | 35.20 | 45.30 | ||||
| Debt / Equity Ratio | 0.09 | 0.09 | 0.55 | 0.18 | 0.13 | |
| Net Debt / Equity Ratio | 0.06 | 0.06 | -0.01 | -1.02 | -1.83 | -1.24 |
| Net Debt / EBITDA Ratio | -0.11 | -0.11 | 0.04 | 0.79 | 0.84 | 1.91 |
| Net Debt / FCF Ratio | -0.36 | -0.36 | 0.01 | 0.77 | 0.75 | 2.65 |
| Asset Turnover | 0.01 | 0.01 | ||||
| Quick Ratio | 9.33 | 9.33 | 0.00 | 1.03 | 0.85 | 1.65 |
| Current Ratio | 9.33 | 9.33 | 1.16 | 1.12 | 0.85 | 1.67 |
| Return on Equity (ROE) | -79.49% | -79.49% | -42.27% | -187.43% | -155.62% | -180.30% |
| Return on Assets (ROA) | -21.28% | -21.28% | -4.97% | -35.07% | -33.93% | -38.45% |
| Return on Capital Employed (ROCE) | -50.80% | -50.80% | -30.00% | -147.10% | -231.90% | -63.80% |
| Earnings Yield | 231.74% | 86.92% | -21.51% | |||
| FCF Yield | -51.24% | -25.34% | -38.45% | |||
| Buyback Yield / Dilution | -22.06% | -22.06% | -2.63% | -0.32% | -40.55% | -23.74% |